Masa Ieda

440 total citations
16 papers, 357 citations indexed

About

Masa Ieda is a scholar working on Psychiatry and Mental health, Biological Psychiatry and Behavioral Neuroscience. According to data from OpenAlex, Masa Ieda has authored 16 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Psychiatry and Mental health, 4 papers in Biological Psychiatry and 4 papers in Behavioral Neuroscience. Recurrent topics in Masa Ieda's work include Stress Responses and Cortisol (4 papers), Tryptophan and brain disorders (4 papers) and Alkaloids: synthesis and pharmacology (3 papers). Masa Ieda is often cited by papers focused on Stress Responses and Cortisol (4 papers), Tryptophan and brain disorders (4 papers) and Alkaloids: synthesis and pharmacology (3 papers). Masa Ieda collaborates with scholars based in Japan and Indonesia. Masa Ieda's co-authors include Tsuyoshi Miyaoka, Jun Horiguchi, Rei Wake, Kristian Liaury, Keiko Tsuchie, Motohide Furuya, Tomoko Araki, Kazunori Kawakami, Takuji Inagaki and Satoko Ezoe and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Neuroinflammation and Progress in Neuro-Psychopharmacology and Biological Psychiatry.

In The Last Decade

Masa Ieda

15 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masa Ieda Japan 9 196 106 84 78 73 16 357
Kristian Liaury Japan 13 229 1.2× 105 1.0× 120 1.4× 121 1.6× 118 1.6× 22 517
F. Macchi Italy 6 205 1.0× 202 1.9× 58 0.7× 62 0.8× 48 0.7× 7 445
Patrick De Haes Belgium 6 184 0.9× 128 1.2× 110 1.3× 180 2.3× 47 0.6× 6 472
Г. Г. Симуткин Russia 12 105 0.5× 68 0.6× 73 0.9× 40 0.5× 77 1.1× 58 346
Halina Marmurowska-Michałowska Poland 8 211 1.1× 150 1.4× 62 0.7× 58 0.7× 100 1.4× 13 362
David Martín‐Hernández Spain 15 289 1.5× 157 1.5× 184 2.2× 87 1.1× 56 0.8× 34 580
Tuya Bao China 15 123 0.6× 123 1.2× 79 0.9× 81 1.0× 56 0.8× 26 487
Danielle Santana‐Coelho United States 6 199 1.0× 127 1.2× 68 0.8× 60 0.8× 55 0.8× 11 330
Keiko Tsuchie Japan 14 340 1.7× 124 1.2× 272 3.2× 130 1.7× 130 1.8× 27 686
Elodie Bouvier France 3 130 0.7× 128 1.2× 93 1.1× 44 0.6× 68 0.9× 3 404

Countries citing papers authored by Masa Ieda

Since Specialization
Citations

This map shows the geographic impact of Masa Ieda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masa Ieda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masa Ieda more than expected).

Fields of papers citing papers by Masa Ieda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masa Ieda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masa Ieda. The network helps show where Masa Ieda may publish in the future.

Co-authorship network of co-authors of Masa Ieda

This figure shows the co-authorship network connecting the top 25 collaborators of Masa Ieda. A scholar is included among the top collaborators of Masa Ieda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masa Ieda. Masa Ieda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Miyaoka, Tsuyoshi, Masa Ieda, Sadayuki Hashioka, et al.. (2015). Analysis of oxidative stress expressed by urinary level of biopyrrins and 8‐hydroxydeoxyguanosine in patients with chronic schizophrenia. Psychiatry and Clinical Neurosciences. 69(11). 693–698. 19 indexed citations
2.
Wake, Rei, Tsuyoshi Miyaoka, Takuji Inagaki, et al.. (2013). Yokukansan (TJ-54) for Irritability Associated with Pervasive Developmental Disorder in Children and Adolescents: A 12-Week Prospective, Open-Label Study. Journal of Child and Adolescent Psychopharmacology. 23(5). 329–336. 9 indexed citations
3.
Yamashita, Satoko, Tsuyoshi Miyaoka, Michiharu Nagahama, et al.. (2013). Treatment of Paroxysmal Perceptual Alteration in Catatonic Schizophrenia by Switching to Aripiprazole from Risperidone: A Case Report. Clinical Schizophrenia & Related Psychoses. 10(1). 37–40. 1 indexed citations
4.
Ieda, Masa, Tsuyoshi Miyaoka, Rei Wake, et al.. (2013). Evaluation of autonomic nervous system by salivary alpha-amylase level and heart rate variability in patients with schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 264(1). 83–87. 33 indexed citations
5.
Miyaoka, Tsuyoshi, Rei Wake, Motohide Furuya, et al.. (2013). Yokukansan (TJ-54) for treatment of very-late-onset schizophrenia-like psychosis: An open-label study. Phytomedicine. 20(7). 654–658. 13 indexed citations
6.
Furuya, Motohide, Tsuyoshi Miyaoka, Rei Wake, et al.. (2013). Possibility of early withdrawal of benzodiazepine hypnotics by combination with ramelteon for the treatment of insomnia: A pilot study. Sleep and Biological Rhythms. 11(1). 55–61. 1 indexed citations
7.
Liaury, Kristian, Tsuyoshi Miyaoka, Toshiko Tsumori, et al.. (2012). Morphological features of microglial cells in the hippocampal dentate gyrus of Gunn rat: a possible schizophrenia animal model. Journal of Neuroinflammation. 9(1). 56–56. 49 indexed citations
8.
Miyaoka, Tsuyoshi, Rei Wake, Motohide Furuya, et al.. (2012). Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger’s disorder: a 12-week prospective, open-label study. BMC Psychiatry. 12(1). 215–215. 16 indexed citations
9.
Tsuchie, Keiko, Tsuyoshi Miyaoka, Motohide Furuya, et al.. (2012). The effects of antipsychotics on behavioral abnormalities of the Gunn rat (unconjugated hyperbilirubinemia rat), a rat model of schizophrenia. Asian Journal of Psychiatry. 6(2). 119–123. 17 indexed citations
10.
Miyaoka, Tsuyoshi, Rei Wake, Motohide Furuya, et al.. (2012). Minocycline as adjunctive therapy for patients with unipolar psychotic depression: An open-label study. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 37(2). 222–226. 174 indexed citations
11.
Ieda, Masa, et al.. (2012). May Salivary Alpha-Amylase Level Be a Useful Tool for Assessment of the Severity of Schizophrenia and Evaluation of Therapy? A Case Report. SHILAP Revista de lepidopterología. 2012. 1–4. 1 indexed citations
12.
Inagaki, Takuji, Masa Ieda, Satoko Yamashita, Tsuyoshi Miyaoka, & Jun Horiguchi. (2011). Salivary Alpha-Amylase Reactivity under Psycho-Physiological Stress. A Nonverbal Communication Measurement Tool?. Journal of Behavioral and Brain Science. 1(1). 12–15. 8 indexed citations
13.
Miyaoka, Tsuyoshi, Masa Ieda, Rei Wake, et al.. (2011). P.7.c.004 Yokukansan for the treatment of pervasive developmental disorder not otherwise specified and Asperger's disorder: an open-label study. European Neuropsychopharmacology. 21. S606–S607. 1 indexed citations
14.
Liaury, Kristian, Tsuyoshi Miyaoka, Toshiko Tsumori, et al.. (2011). Morphological features of microglial cells in the dentate gyrus of Gunn rats: A possible schizophrenia animal model. Neuroscience Research. 71. e393–e394. 1 indexed citations
15.
Miyaoka, Tsuyoshi, Motohide Furuya, Kristian Liaury, et al.. (2010). Yi-Gan San for Treatment of Charles Bonnet Syndrome (Visual Hallucination Due to Vision Loss). Clinical Neuropharmacology. 34(1). 24–27. 14 indexed citations
16.
Takatsuki, Seiji, et al.. (2001). Efficacy of intravenous nifekalant, a pure Ikr blocker, for atrial tachyarrhythmia with heart failure. 22(4). 852–855.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026